Sensitive coronavirus testing.
A new corona test developed at the University Hospital Bonn can simultaneously analyse a large number of swabs using sequencing technology and has a similarly high sensitivity to the common qPCR tests. The innovative method offers great potential for rapid systematic testing without the drawbacks of most methods.
The test is described in Nature Biotechnology: https://www.nature.com/articles/s41587-021-00966-9
#sciencenews #coronavirus #molecularbiology
A new corona test developed at the University Hospital Bonn can simultaneously analyse a large number of swabs using sequencing technology and has a similarly high sensitivity to the common qPCR tests. The innovative method offers great potential for rapid systematic testing without the drawbacks of most methods.
The test is described in Nature Biotechnology: https://www.nature.com/articles/s41587-021-00966-9
#sciencenews #coronavirus #molecularbiology
Nature
LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding
Nature Biotechnology - SARS-CoV-2 detection with LAMP-Seq combines isothermal amplification and barcoding with high-throughput sequencing.
Mefloquine – fighting coronavirus.
Scientists from Tokyo University of Science have identified the anti-malarial drug mefloquine as being effective against SARS-CoV-2. They show that the drug effectively limits the entry of the virus into the cells.
Learn about their insight in Frontiers in Microbiology: https://doi.org/10.3389/fmicb.2021.651403
#sciencenews #coronavirus #healthcare #medicine
Scientists from Tokyo University of Science have identified the anti-malarial drug mefloquine as being effective against SARS-CoV-2. They show that the drug effectively limits the entry of the virus into the cells.
Learn about their insight in Frontiers in Microbiology: https://doi.org/10.3389/fmicb.2021.651403
#sciencenews #coronavirus #healthcare #medicine
Frontiers
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and economic damage worldwide and effective drugs that prevent or cure COVID-19 are urgently needed. Approved drugs including Hydroxychloroquine, Remdesivir or Interferon were reported…